Dimitris Voliotis's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 24,234 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,234 | 24,234 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 10,329 | 16,579 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 10 Feb 2022 | 534 | 16,045 | - | 50.2 | 26,788 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 10 Feb 2022 | 67 | 15,978 | - | 50.7 | 3,400 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 18 Jan 2022 | 10,000 | 16,250 | - | 18 | 180,000 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 18 Jan 2022 | 10,000 | 16,250 | - | 18 | 180,000 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,000 | 144,949 | - | - | Stock Option | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,000 | 134,949 | - | - | Stock Option | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,000 | 124,949 | - | - | Stock Option | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 18 Jan 2022 | 10,000 | 16,250 | - | 18 | 180,000 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 60.52 per share. | 18 Jan 2022 | 8,343 | 7,907 | - | 60.5 | 504,904 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 60.55 per share. | 18 Jan 2022 | 7,889 | 8,361 | - | 60.6 | 477,683 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 61.70 per share. | 18 Jan 2022 | 3,409 | 12,841 | - | 61.7 | 210,326 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 62.34 per share. | 18 Jan 2022 | 3,294 | 9,547 | - | 62.3 | 205,334 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 63.48 per share. | 18 Jan 2022 | 1,997 | 7,550 | - | 63.5 | 126,767 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 18 Jan 2022 | 1,657 | 6,250 | - | 61.2 | 101,419 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 61.51 per share. | 18 Jan 2022 | 1,556 | 6,805 | - | 61.5 | 95,707 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 64.66 per share. | 18 Jan 2022 | 1,300 | 6,250 | - | 64.7 | 84,064 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Sale of securities on an exchange or to another person at price $ 62.24 per share. | 18 Jan 2022 | 555 | 6,250 | - | 62.2 | 34,541 | Common Stock |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 18,750 | 18,750 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Dimitris Voliotis | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,250 | 6,250 | - | 0 | Common Stock |